Skip to main content

US ClosedU.S. Closed

VERU: Veru Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Veru Inc. operates as a biopharmaceutical firm primarily dedicated to advancing novel therapeutic agents for various types of cancer.

52W Range

11thpctl

Volume

0.05×avg

Market Cap

42.13MUSD

P/E Ratio

-4.4TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Veru Inc.

VERUNASDAQ Capital Market·USD·Closed

Veru Inc.

VERUNASDAQ·USD·Closed

$2.63

−4.20%

$2.63

−$0.12 (4.20%)

52W Range

11thpctl

Volume

0.05×avg

Mkt Cap

42.13MUSD

P/E

-4.4TTM

Div Yield

–ann